Infliximab in the treatment of plaque type psoriasis

Infliximab in the treatment of plaque type psoriasis

Rosita Saraceno, Andrea Saggini, Lucia Pietroleonardo, Sergio ChimentiDepartment of Dermatology, University of Rome Tor Vergata, Rome, Viale Oxford 81, Rome, ItalyAbstract: Psoriasis is a chronic and immunomediated skin disease characterized by erythematous scaly plaques. Psoriasis affects approxima...

Full description

Bibliographic Details
Main Authors:	Rosita Saraceno, Andrea Saggini, Lucia Pietroleonardo, Sergio Chimenti
Format:	Article
Language:	English
Published:	Dove Medical Press 2009-04-01
Series:	Clinical, Cosmetic and Investigational Dermatology
Online Access:	http://www.dovepress.com/infliximab-in-the-treatment-of-plaque-type-psoriasis-a3022

Similar Items

Pulmonary tuberculosis and choroidal granuloma in a patient with severe chronic plaque psoriasis treated with infliximab
by: Vani, B, et al.
Published: (2007)

Neurological symptoms in psoriasis patients under treatment with infliximab
by: Elham Behrangi, et al.
Published: (2015-10-01)

Effectiveness of infliximab biosimilars in the treatment of moderate to severe chronic plaque psoriasis: experience of real-world data from the register of the program “Treatment of moderate and severe forms of plaque psoriasis (B.47)” of the National Health Fund in Poland
by: Witold Owczarek, et al.
Published: (2021-08-01)

Association of Streptococcus with Plaque Type of Psoriasis
by: Mohammad Akram Hossain, et al.
Published: (2015-05-01)

Tuberculose esplênica durante tratamento de psoríase com infliximabe Splenic tuberculosis during psoriasis treatment with infliximab
by: Gleyce Tavares de Melo Fortaleza, et al.
Published: (2009-08-01)

The significance of secukinumab in the treatment of plaque psoriasis
by: Marta Kasprowicz-Furmańczyk, et al.
Published: (2022-02-01)

Study of efficacy of bath PUVA therapy in the treatment of generalized plaque type psoriasis
by: Azadeh S, et al.
Published: (1999-09-01)

The onset of psoriasis during the treatment of inflammatory bowel diseases with infliximab: should biological therapy be suspended?
by: Rafael Denadai, et al.
Published: (2012-06-01)

Bimekizumab in the Treatment of Plaque Psoriasis: Focus on Patient Selection and Perspectives
by: Camiña-Conforto G, et al.
Published: (2023-06-01)

Diacerein in the treatment of chronic plaque psoriasis: A case report
by: Kalgi Baxi, et al.
Published: (2022-01-01)

Stigmatization among Patients with Plaque Psoriasis
by: Barbara Jankowiak, et al.
Published: (2023-10-01)

Psoriasis paradox—infliximab-induced psoriasis in a patient with Crohn’s disease: a case report and mini-review
by: Reem Hamdy A Mohammed, et al.
Published: (2023-09-01)

Brodalumab in the Treatment of Plaque Psoriasis Localized in Difficult-to-Treat Areas: a Narrative Review
by: Maria Vittoria Cannizzaro, et al.
Published: (2023-07-01)

Saudi consensus statement on biologic treatment of chronic plaque psoriasis (2020)
by: Mohammad Ibrahim Ahmad Fatani, et al.
Published: (2022-05-01)

Characterization of responder groups to secukinumab treatment in moderate to severe plaque psoriasis
by: Andreas Pinter, et al.
Published: (2020-11-01)

Certolizumab pegol: new opportunities for treatment of moderate to severe plaque psoriasis
by: A. A. Kubanov, et al.
Published: (2019-12-01)

Treatment of moderate‐to‐severe plaque psoriasis with tildrakizumab in the real‐life setting
by: Alessio Gambardella, et al.
Published: (2023-03-01)

A STUDY ON TOPICAL CALCIUM DOBESILATE FOR THE TREATMENT OF LIMITED PLAQUE PSORIASIS
by: Neerja Puri, et al.
Published: (2013-07-01)

Methotrexate dosing regimen for plaque-type psoriasis: an update of a systematic review
by: Astrid M. van Huizen, et al.
Published: (2022-11-01)

Nail involvement in adult patients with plaque-type psoriasis: prevalence and clinical features
by: Karen Regina Rosso Schons, et al.
Published: (2015-06-01)

Ayurvedic Management in a Case of Plaque Psoriasis
by: Khushhali Balpande, et al.
Published: (2023-12-01)

Myeloperoxidase Inhibition Ameliorates Plaque Psoriasis in Mice
by: Savannah D. Neu, et al.
Published: (2021-08-01)

Evaluation of pancreatic function in patients with plaque psoriasis
by: Agnieszka Białecka
Published: (2023-07-01)

Quality of life in patients with mild plaque psoriasis
by: Xiaoyu QIU, et al.
Published: (2023-04-01)

Association between infliximab concentrations and clinical response in psoriasis: a prospective cohort study
by: M. Colls-Gonzalez, et al.
Published: (2021-02-01)

Infliximab for the treatment of rheumatoid arthritis.
by: Blumenauer, B, et al.
Published: (2002)

The Risk of COVID-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments
by: Paolo Gisondi, et al.
Published: (2020-12-01)

Successful therapy of plaque-type psoriasis with secukinumab in patients with multiple comorbidities treated with previous biologic therapies
by: Claudia Lasagni, et al.
Published: (2018-12-01)

Efficacy and safety of biosimilar infliximab CT-P13 in the treatment of psoriasis and psoriatic arthritis: 1-year follow-up
by: Patricia Shu Kurizky, et al.
Published: (2019-10-01)

Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study—IL PSO (Italian landscape psoriasis)
by: Luigi Gargiulo, et al.
Published: (2023-08-01)

Infliximab
by: İlgen Ertam Sağduyu
Published: (2022-04-01)

Targeted phototherapy of plaque-type psoriasis using ultraviolet B-light-emitting diodes.
by: Kemény, L, et al.
Published: (2010)

Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes
by: Alexander Egeberg, et al.
Published: (2023-01-01)

Circulating Irisin Levels in Patients with Chronic Plaque Psoriasis
by: Francesca Ambrogio, et al.
Published: (2022-08-01)

Efficacy and safety of ixekizumab in Chinese patients with plaque psoriasis
by: He Huang, et al.
Published: (2023-02-01)

Central Pain Sensitization in Patients with Chronic Plaque Psoriasis
by: Francesco Bellinato, et al.
Published: (2023-03-01)

Infliximab and methotrexate in the treatment of rheumatoid arthritis
by: Lipsky, P, et al.
Published: (2000)

INFLIXIMAB IN TREATMENT OF REFRACTORY JUVENILE ARTHRITIS
by: I.P. Nikishina, et al.
Published: (2010-01-01)

INFLIXIMAB IN TREATMENT OF REFRACTORY JUVENILE ARTHRITIS
by: I.P. Nikishina, et al.
Published: (2010-01-01)

INFLIXIMAB IN TREATMENT OF ACTIVE JUVENILE ARTHRITIS
by: E. S. Zholobova, et al.
Published: (2012-05-01)